6,678 trials
Proliferative Diabetic Retinopathy · Diabetic Traction Retinal Detachment · Vitreous Hemorrhage
Primary: Reoperation — 1; 7 participants — p=0.033
Adrenal Insufficiency
Primary: Change in Cognition After 10 Weeks of Treatment With a Low Dose of Hydrocortisone Compared to 10 Weeks of Treatment With a High Dose of Hydrocortisone. — -0.41; -0.42…
Rheumatoid Arthritis
Primary: Disease Activity Score Based on 28-Joint Count (DAS28) — 6.03; 4.01 units on a scale — p=<0.0001
Liver Transplantation
Primary: Percentage of Participants With Treated Biopsy Proven Acute Rejection (BPAR) According to Banff Criteria up to 12 Months Post-Transplant — 8.0; 8.2 percentage of…
Plaque Psoriasis
Primary: Subject Reported Target Lesion Severity Score. — 4.0 units on a scale
Arthroscopic Knee Surgery
Primary: Efficacy of IV Ibuprofen for Post-op Pain. — 8; 34; 19; 41 units on a scale
Fabry Disease
Primary: Percent Change From Baseline in Plasma Deacylated Globotriaosylceramide (Lyso-GL-3) at Month 2, 4 and 6 — -31.71; -39.04; -39.54 percent change — p=0.0002
Uveitis
Primary: Number of Eyes With Inflammation Recurrence — 1 eye with inflammation
Bronchiectasis
Primary: 24 Hour Sputum Volume — 41.8; 23.6; 29.9; 26.2 gram — p=<0.01
Irritable Bowel Syndrome · Generalized Anxiety Disorder
Primary: Clinical Global Impression Scale — 2.64 scores on a scale
Coronary Artery Bypass Surgery · Elective Surgical Procedure
Primary: Endothelial Progenitor Cells (EPCs) Count (Cells/µl) — 5.00; 2.19 cells/µl
Allergic Rhinitis
Primary: Change in Tryptase Level From Baseline to Post-antigen Challenge — 0; 2.31 mcg/L — p=0.33
Hypertension · Diabetes Mellitus, Type II
Primary: Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Month 6 — 6.79; 0.26 Percent HbA1c
Nasolabial Folds
Primary: Rate of Severe Common Adverse Events — 8.5 percentage of 'severe' common AEs — p=< 0.025
Bone Loss · Osteoporosis · Breast Cancer
Primary: BMD of Spine by DXA — 2.269; -1.735 percentage change